Friday 6 November 2026 Export RDNT’s income statement to Excel — free account

RadNet, Inc.

RadNet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 11.5% from fiscal 2024.

Revenue: +25.0%
EPS: −47.4%
Free cash flow: −43.2%
Total debt: +21.2%

Quarter to June 2026, against a year earlier

78.45 1.81 −2.26%

Follow RDNT

Alert me

Market cap: $6.1B
P/E: 0.0×
Fwd P/E: 1,050×
Dividend yield: —
F-score: 3/9
Altman Z: 2.04
Beneish M: −2.62
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

RadNet, Inc. (RDNT) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2025: revenue by segment, and margins
Imaging Center	1,988	97.45%
Digital health	52	2.55%
Gross margin		11.54%
Operating margin		3.04%
Pre-tax margin		1.56%

Revenue by product or service $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Commercial insurance	1,130 55.39%	1,018 55.66%	880 54.42%	770 53.83%	743 56.53%	584 54.49%	642 55.65%	542 55.58%
Medicare	477 23.38%	410 22.41%	357 22.05%	305 21.33%	281 21.36%	218 20.33%	237 20.57%	193 19.78%
Revenue under capitation arrangements	126 6.15%	137 7.46%	153 9.49%	152 10.63%	148 11.28%	140 13.07%	126 10.91%	106 10.91%
Other payors	119 5.81%	105 5.73%	88 5.42%	66 4.61%	—	—	—	—
Other revenue	65 3.19%	47 2.55%	33 2.02%	27 1.90%	12 0.95%	23 2.17%	25 2.13%	19 1.93%
Medicaid	52 2.54%	45 2.45%	42 2.62%	38 2.62%	35 2.64%	26 2.39%	28 2.45%	26 2.63%
Workers' compensation/personal injury	45 2.19%	44 2.39%	46 2.87%	50 3.52%	44 3.36%	33 3.12%	43 3.71%	34 3.51%
Management fee revenue	28 1.35%	25 1.35%	18 1.11%	22 1.55%	20 1.49%	11 1.05%	12 1.01%	14 1.42%
Other patient revenue	—	—	—	—	19 1.48%	25 2.36%	24 2.07%	25 2.58%
Software and Teleradiology	—	—	—	—	11 0.80%	11 1.01%	17 1.50%	16 1.67%
Ai	—	—	—	—	1 0.11%	0 0.00%	—	—
Health Care, Patient Service	1,915	1,693	1,463	1,278	1,167	932	1,028	869
Imaging Center Segment Revenue	—	—	—	—	1,314	1,072	—	—
Revenue	2,040	1,830	1,617	1,430	1,315	1,072	1,154	975

Revenue by segment $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Imaging Center	1,988 97.45%	1,792 97.96%	1,591 98.39%	1,413 98.84%	1,314 99.89%	1,072 100.00%
Digital health	52 2.55%	37 2.04%	26 1.61%	17 1.16%	—	—
Ai	—	—	—	—	1 0.11%	0 0.00%
Revenue	2,040	1,830	1,617	1,430	1,315	1,072

Operating income by segment $m, and margin

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Imaging Center	‡	‡	‡	‡	‡	‡
Digital health	‡	‡	‡	‡	‡	‡
Corporate and other	‡	‡	‡	‡	‡	‡
Operating income	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡

Revenue by region $m

Line	FY2025	FY2024	FY2023	FY2022
United States	2,006 98.33%	1,802 98.51%	1,600 98.96%	1,423 99.52%
Other countries	34 1.67%	27 1.49%	17 1.04%	2 0.17%
United Kingdom	—	—	—	4 0.31%
Revenue	2,040	1,830	1,617	1,430

Operating figures as reported in each quarter’s results release or filing

Figure	Quarter	Latest	A year before	Change
Advanced imaging as a percentage of total procedural volumes	Q2 FY2026	29.9%	27.5%	—
Aggregate advanced imaging procedural volume growth	Q2 FY2026	21.2%	9.00%	—
Aggregate procedural volume growth	Q1 FY2026	10.1%	3.60%	—
Centers held in partnership with leading health systems	Q2 FY2026	157.00	—	—
Centers held in partnership with leading health systems	Q2 FY2026	36.0%	—	—
CT procedures	Q2 FY2026	352.7K	291.8K	+20.87%
CT volume growth	Q2 FY2026	20.9%	8.10%	—
Imaging centers	Q2 FY2026	442.00	405.00	+9.14%
Mammography procedures	Q1 FY2026	504.8K	476.4K	+5.96%
MRI procedures	Q2 FY2026	593.1K	490.3K	+20.98%
MRI volume growth	Q2 FY2026	21.0%	9.00%	—
Nuclear medicine procedures	Q1 FY2026	10.4K	9.6K	+8.54%
PET/CT procedures	Q2 FY2026	29.0K	22.2K	+31.02%
PET/CT volume growth	Q2 FY2026	31.0%	22.4%	—
Same-center advanced imaging procedural volume growth	Q2 FY2026	9.60%	6.60%	—
Same-center CT volume growth	Q2 FY2026	8.60%	5.90%	—
Same-center MRI volume growth	Q2 FY2026	10.2%	6.60%	—
Same-center PET/CT volume growth	Q2 FY2026	8.80%	16.2%	—
Same-center procedural volume growth	Q1 FY2026	2.40%	—	—
Total procedures	Q1 FY2026	3.0M	2.7M	+10.13%
Ultrasound procedures	Q1 FY2026	718.0K	656.4K	+9.38%
X-ray and other procedures	Q1 FY2026	903.0K	861.7K	+4.79%

	Q2 FY2026	Q1 FY2026	Q4 FY2025	Q3 FY2025	Q2 FY2025	Q1 FY2025	Q4 FY2024	Q3 FY2024	Q2 FY2024	Q1 FY2024	Q4 FY2023	Q3 FY2023
Advanced imaging as a percentage of total procedural volumes	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Aggregate advanced imaging procedural volume growth	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Aggregate procedural volume growth	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Centers held in partnership with leading health systems	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Centers held in partnership with leading health systems	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
CT procedures	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
CT volume growth	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Imaging centers	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Mammography procedures	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
MRI procedures	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
MRI volume growth	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Nuclear medicine procedures	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
PET/CT procedures	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
PET/CT volume growth	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Same-center advanced imaging procedural volume growth	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Same-center CT volume growth	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Same-center MRI volume growth	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Same-center PET/CT volume growth	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Same-center procedural volume growth	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Total procedures	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Ultrasound procedures	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
X-ray and other procedures	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.